Work

The efficacy and safety of trastuzumab deruxtecan (T-DXd) in HER2-positive and -low metastatic breast cancer with brain metastases (BCBM): A retrospective, multicenter, real-world study.

Year: 2025

Type: article

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e13120

Authors: Qingru Zhou, Yuanyuan Li, Guorong Zou, Mengqian Ni, Shu Dun, Zhanhong Chen, Kejun Liu, Zhongyu Yuan, Shusen Wang, Yanxia Shi, Yinsheng Chen, Yonggao Mou, Anli Yang, Lixia Li, Xin An

Institutions: Sun Yat-sen University, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Panyu District Central Hospital, Dongguan People’s Hospital, Guangdong Medical College

Language: English

Topic: Brain Metastases and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410804419

FWCI: 1.215

Cites:

Cited by: 2

Related to: 10